NASDAQ: CTSO
Cytosorbents Corp Stock Ownership - Who owns Cytosorbents?

Insider buying vs selling

Have Cytosorbents Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Phillip P. ChanChief Executive Officer2026-06-1510,333$0.43
$4.44kBuy
Peter J. MarianiChief Financial Officer2026-06-15100,000$0.44
$44.00kBuy
Phillip P. ChanChief Executive Officer2026-06-12251,136$0.40
$100.45kBuy
Phillip P. ChanChief Executive Officer2025-11-18100,000$0.64
$64.00kBuy

1 of 1

CTSO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CTSO insiders and whales buy or sell their stock.

CTSO Shareholders

What type of owners hold Cytosorbents Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
David Lamadrid12.48%7,837,500$3.13MInsider
Avenir Corp8.31%5,215,776$2.08MInstitution
Guillermina Vega Montiel7.95%4,993,984$1.99MInsider
Margie Chassman7.64%4,795,000$1.91MInsider
Robert Shipley4.73%2,972,819$1.19MInsider
Njtc Investment Fund LP4.07%2,554,999$1.02MInsider
Vanguard Capital Management LLC2.99%1,879,989$750.12kInstitution
Phillip P. Chan2.78%1,744,432$696.03kInsider
Skylands Capital LLC2.72%1,707,498$681.29kInstitution
Neuberger Berman Group LLC2.68%1,683,007$671.52kInstitution

1 of 3

CTSO vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CTSO26.23%45.80%Net BuyingNet Buying
LFWD0.05%99.95%Net Selling
PLSM5.21%30.99%
MOVE0.41%99.59%Net BuyingNet Buying
CNSY28.02%71.98%Net Buying

Cytosorbents Stock Ownership FAQ

Who owns Cytosorbents?

Cytosorbents (NASDAQ: CTSO) is owned by 26.23% institutional shareholders, 45.80% Cytosorbents insiders, and 27.97% retail investors. David Lamadrid is the largest individual Cytosorbents shareholder, owning 7.84M shares representing 12.48% of the company. David Lamadrid's Cytosorbents shares are currently valued at $2.82M.

If you're new to stock investing, here's how to buy Cytosorbents stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.